empagliflozin glp-1 New Guidelines for Type 2 Diabetes in 2025 How GLP-1 medications are transforming

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

Studies show up to 25-39% of weight lost on GLP-1s can come from lean mass - without intentional resistance training and adequate protein

Curcumin activated GPR55 and induced serum-response element- and serum-response factor-mediated transcription, which were inhibited by Rho kinase and GPR55 antagonists

A new KFF analysis estimates that 3.8 million Medicare Part D enrollees could qualify for the Medicare GLP-1 Bridge program, which began July 1 and provides temporary coverage of GLP-1s for weight reduction for eligible beneficiaries through December 2027.

In a TikTok video shared by t...

Two announcements this week, on opposite ends of healthcare: Queue raised money to build autonomous robotic pharmacies